We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

66 hedge funds and large institutions have $202M invested in TriSalus Life Sciences in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 7

46% more capital invested

Capital invested by funds: $139M → $202M (+$63.5M)

27% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 11

25% more funds holding

Funds holding: 53 → 66 (+13)

23.85% more ownership

Funds ownership: 57.62% → 81.46% (+24%)

Holders
66
Holders Change
+13
Holders Change %
+24.53%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
14
Reduced
11
Closed
7
Calls
$134K
Puts
–
Net Calls
+$134K
Net Calls Change
+$71K

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$17.1M
2
HP
Hartree Partners
New York
+$16.9M
3
DM
Deerfield Management
New York
+$9.79M
4
GGHC
Gilder Gagnon Howe & Co
New York
+$6.94M
5
GCL
Glazer Capital LLC
New York
+$6.36M

Top Sellers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
-$12.1M
2
Citadel Advisors
Citadel Advisors
Florida
-$3.01M
3
PAMP
Polar Asset Management Partners
Ontario, Canada
-$2.76M
4
Verition Fund Management
Verition Fund Management
Connecticut
-$2.61M
5
SCM
Shaolin Capital Management
Florida
-$2.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
OCAM
51
Owl Creek Asset Management
New York
$397K – – –
MSU
52
Mizuho Securities USA
New York
$362K +$357K +36,490 New
GH
53
GAM Holding
Switzerland
$318K +$313K +32,000 New
Creative Planning
54
Creative Planning
Kansas
$248K +$245K +25,000 New
TAL
55
TIG Advisors LLC
New York
$231K -$12K -1,226 -5%
TCM
56
Tenor Capital Management
New York
$199K – – –
KKRC
57
Kohlberg Kravis Roberts & Co
New York
$195K +$192K +19,601 New
CI Investments Inc
58
CI Investments Inc
Ontario, Canada
$193K +$190K +19,400 New
Geode Capital Management
59
Geode Capital Management
Massachusetts
$184K – – –
DFCM
60
Dark Forest Capital Management
Puerto Rico
$136K +$134K +13,662 New
AA
61
Ancora Advisors
Ohio
$51K +$49.9K +5,100 New
ACA
62
Arena Capital Advisors
California
$43K +$1.03K +105 +3%
Morgan Stanley
63
Morgan Stanley
New York
$42K +$40.2K +4,104 +4,104%
TRCT
64
Tower Research Capital (TRC)
New York
$7K +$6.78K +693 New
Walleye Capital
65
Walleye Capital
New York
$123 +$122K +12,414 New
PWAM
66
Park West Asset Management
California
– -$12.1M -1,250,000 Closed
SCM
67
Shaolin Capital Management
Florida
– -$2.42M -250,000 Closed
JGC
68
J. Goldman & Co
New York
– -$1.81M -187,020 Closed
MS
69
Maven Securities
Jersey
– -$789K -80,681 Closed
PI
70
PEAK6 Investments
Illinois
– -$245K -25,308 Closed
CIC
71
Chilton Investment Company
Connecticut
– -$194K -20,000 Closed
WMSA
72
Weiss Multi-Strategy Advisers
New York
– -$104K -10,758 Closed
UBS Group
73
UBS Group
Switzerland
– -$11.2K -1,143 -99%
1 2
3

TLSI Hedge Fund Activity: Q3 2021 in Review

66 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q3 2021, worth a combined $202M — up 46% from $139M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TLSI positions and 7 closed out — a net gain of 13 holders — while 14 added to existing stakes and 11 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $17.1M. The largest seller was Park West Asset Management, exiting entirely with an estimated $12.1M sold.

  • 66 institutional investors held TriSalus Life Sciences (TLSI) as of Q3 2021, up from 53 in Q2 2021.
  • Funds reported $202M of TriSalus Life Sciences stock for Q3 2021, up 46% quarter-over-quarter.
  • 20 funds opened new TriSalus Life Sciences positions in Q3 2021 and 7 closed out, a net change of +13 holders.
  • The largest TriSalus Life Sciences buyer in Q3 2021 was Magnetar Financial, an estimated $17.1M added.
  • The largest TriSalus Life Sciences seller in Q3 2021 was Park West Asset Management, an estimated $12.1M sold.

Based on aggregated 13F filings for Q3 2021.